Cancer BiologyCancer ResearchPeer-reviewed
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma
Mona Foth, Wontak Kim, Kayla T. O’Toole…·Martin McMahon
This study identifies RAS(ON) inhibitors effective against NRAS-mutated melanoma and reveals resistance mechanisms through Ppia and Map2k1 mutations.
5 citationstop 1%